XGen Pharmaceuticals DJB
Rick Pfeiffer has a diverse and extensive work experience spanning over several decades. Rick most recently served as the Retired Vice President at XGen Pharmaceuticals DJB, starting in January 2009 and retiring in December 2020. Prior to this, they held the role of Vice President, Governance at the same company.
Before joining XGen Pharmaceuticals DJB, Rick worked as a Business Operations Consultant at mEnterprise Solutions in 2007. Rick also has experience as a Commissioner at Fire District 1 from 1985 to 2006.
In terms of their expertise in facilities management and operations, Rick held positions of Global Facilities & Assets Manager - Power Amplifiers at Andrew Corporation from 2002 to 2005 and Corporate Facilities Manager at Celiant Corporation in 2001. Furthermore, their experience includes being an Operations Manager at Lucent Technologies from 1995 to 2001, and a Finance Manager at AT&T from 1970 to 1995.
Rick Pfeiffer's education history includes attending Rahway HS for an unknown duration, although the specific years are not provided. There is no information available regarding any further education or degrees obtained.
This person is not in the org chart
This person is not in any offices
XGen Pharmaceuticals DJB
Approaching the end of a 20 year career at a major pharmaceutical company, Dan Badia made a discovery. Where larger companies found obsolescence in small markets or low-profit yielding drugs, Dan saw reliable solutions proven to be effective and affordable alternatives for healthcare. With his wife, Shirley Harmening, Dan founded a company in 1973 on a bridge table in his bedroom. In just 14 years, this company would outgrow its birthplace and find a home in lower upstate New York. That growth would be sustained by introducing injectables into an established product line, mainly consisting of anti-infective, compounding powders. In 2003, that company would become X-GEN Pharmaceuticals, Inc. Affirming Dan’s original vision while embracing a dynamic industry, family-owned X-GEN Pharmaceuticals, Inc. remained a leader in generic, anti-infective pharmaceuticals. In this our 50th year in affiliation, we honor this heritage by carrying our founder’s initials in our new name, XGen Pharmaceuticals DJB. With reverence for the past and a passion for the future, we expect big results, driven by bold solutions and delivered by real people.